This study is designed to test if a sequential protease-inhibitor (PI) - / nevirapine (NVP)
-based regimen is effective for the treatment of HIV-infected children when previous NVP
exposure has occurred as part of programs to prevent mother-to-child transmission (pMTCT).
Phase:
Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators:
Columbia University University of Witwatersrand, South Africa